Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkins ...